Three cases with CD8+ small-to medium-sized lymphoproliferations in the skin at extrafacial sites are described. Clinically, the patients presented with papulonodular or plaque-like lesions without preceding patches. Histopathologically, nonepidermotropic nodular or diffuse infiltrates were composed of small-to mediumsized pleomorphic lymphocytes, which expressed CD8 (more than 80% of the cells) and granzyme B (60%-70% of the cells), but were negative for CD4, CD30, and CD56. There was no association with Epstein-Barr virus. A clonal T-cell population was detected in 2 patients. Staging examinations did not reveal extracutaneous involvement. The 2 patients with solitary lesions underwent complete remission after radiation therapy, whereas 1 patient developed multifocal lesions and several recurrences. These CD8+ small-to medium-sized lymphoproliferations of the skin at extrafacial sites may belong to a spectrum of phenotypically and prognostically heterogeneous cutaneous small-to medium-sized lymphoid proliferations, which are characterized by an indolent course in most patients.
INTRODUCTION
In the recent literature, there have been several reports of unusual proliferations of CD8+ lymphocytes of the skin that posed diagnostic problems, especially with regard to their classification according to the currently used schemes and particularly the World Health Organization/European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. [1] [2] [3] [4] Those cases clearly differed from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (CD8+AECTCL) and from other lymphoma types with CD8 expression such as subcutaneous panniculitis-like T-cell lymphoma and lymphomas with occasional expression of CD8 such as mycosis fungoides (MF), cutaneous gamma/delta T-cell lymphoma, and extranodal natural killer (NK)/T-cell lymphoma, nasal type. [5] [6] [7] [8] Cases in which the lesions were located on the face, often involving the ear, have been referred to as "indolent CD8-positive lymphoid proliferation of the ear and face," respectively, are characterized by nodular infiltrates of small-to medium-sized CD8-positive lymphocytes. Only 2 patients with a nodular infiltrate of CD8+ small-to medium-sized lymphocytes have been reported in extrafacial locations. 9, 10 A common clinical feature of the reported cases of CD8+ small-to medium-sized lymphoid infiltrates was an indolent course, which is in contrast to a rare subset of peripheral CTCL, not otherwise specified (NOS) with a cytotoxic phenotype that usually follows an aggressive course. 11 Some authors feel that the infiltrates of CD8+ small-to medium-sized lymphocyte cases are morphologically related to primary cutaneous CD4+ small/ medium-sized pleomorphic T-cell lymphoma (SMPTL) except for the fact that the small-to medium-sized lymphocytes in SMPTL express CD4. [1] [2] [3] [4] Here, we present the clinicopathologic features of 3 cases of extrafacial proliferations of small-to medium-sized CD8+ lymphocytes of the skin and discuss their possible categorization.
MATERIALS AND METHODS
A total of 6 biopsies from 3 patients were available for a histopathologic review. Biopsy specimens were fixed in 10% buffered formalin, and sections were routinely processed and embedded in paraffin. Serial 4-mm-thick sections were cut for hematoxylin and eosin stains and immunohistochemical stains. The antibodies used for immunohistochemistry included CD2 (1:50; Novocastra/ Leica-Microsystems, Heerbrugg, Switzerland), CD3 (1:75; Dako, Glostrup, Denmark), CD4 (1:2; Novocastra/ Leica-Microsystems), CD7 (1:25; Dako), CD8 (1:400; Dako), CD20 (1:600; Dako), CD30 (1:75; Novocastra/ Leica-Microsystems), CD56 (RTU; Novocastra/Leica-Microsystems), and T-cell-restricted intracellular autigen-1 (TIA-1) (1:50; Immunotech, Marseille, France) and granzyme B (1:50; Dako), perforin (1:20; Novocastra/Leica-Microsystems), and beta F1 (1:50; Thermo Scientific, Germany). Immunostaining was performed according to standard protocols using alkaline phosphatase-antialkaline phosphatase method, avidin-biotin complex, or streptavidin-biotin complex labeled with peroxidase or alkaline phosphatase. Appropriate positive and negative controls were applied. The antibody panel used differed in individual cases depending on the availability of the tissue/antibodies.
In all cases, molecular T-cell receptor rearrangement studies were performed using a multiplex polymerase chain FIGURE 1. Patient 1: Clinicopathologic findings. A, A scaly brownish plaque on the left foot was present at initial presentation. B, Relapse with erythematous papules developed adjacent to the site of previous radiation therapy. C, Superficial and deep nodular and confluent infiltrates were present in all dermal layers (H&E, original magnification ·20). D, The infiltrates consisted of small-to medium-sized pleomorphic lymphocytes with chromatin-dense nuclei (H&E, original magnification ·400). E, There is a granulomatous component with sarcoid-like granulomas and numerous smallto medium-sized lymphocytes with nuclear atypia (H&E, original magnification ·200). F, CD8 (red) is expressed by more than 80% of the small-to medium-sized lymphocytes (immunohistochemistry, original magnification ·200). G, Only small lymphocytes accounting for less than 20% of the infiltrate express CD4 (red) (immunohistochemistry, original magnification ·200). H, Proliferative activity is found in less than 10% of small-to mediumsized pleomorphic lymphocytes. H&E, hematoxylin and eosin. reaction as described elsewhere. 12 Appropriate positive and negative controls were included in all analyses. Also, in situ hybridization for Epstein-Barr virus (EBV) was performed.
RESULTS

Clinical Data Case 1
A 48-year-old man presented in June 2007 with an erythematous nodule (diameter 1 cm) on the right buttock. He had Bruton X-linked agammaglobulinemia that had been treated with immunoglobulin substitution for the previous 21 years. The lesion was excised. Three years later in April 2011, he developed infiltrated tan plaques on the dorsal aspects of the left foot and toes (Fig. 1A) . The working histopathologic diagnosis was "suspicious for cytotoxic lymphoma," so the patient was investigated to exclude extracutaneous disease (including peripheral blood studies and PET-CT), but no extracutaneous involvement was found. In May 2010, the lesions were treated with radiation therapy (total dose 32 Gy using 100 kV) with complete regression. In March 2011, a relapse with plaques on the left foot was observed ( Fig. 1B ) that was treated again with radiation therapy (total dose 52 Gy using 40 kV; March to June 2011), which again resulted in complete regression. Three months later, the patient developed the second recurrence of small livid papules on the left foot adjacent to the radiation site and in addition 3 small papulonodular lesions (diameter up to 8 mm) in the right retroauricular area. The staging examinations (peripheral blood studies, PET/CT) were repeated and were once again negative. In parallel to the superficial x-ray irradiation for the retroauricular lesions, treatment with low-dose methotrexate (15 mg/wk) was started in November 2011 and was alive with disease at the last follow-up in January 2012. Several biopsies of the lesions on the right buttock, the lesions on the feet, and the retroauricular papulonodular lesions were histologically examined.
Case 2
An 87-year-old woman presented with a solitary, red, infiltrated, nonscaling plaque (diameter 5 cm) on the right lower leg (Fig. 2 ). Her medical history was unremarkable for skin or neoplastic diseases. The clinical examination did not reveal enlarged lymph nodes. The lesion was treated by radiation therapy (total dose 50 Gy). No recurrence was observed during follow-up of 2 years.
Case 3
A 52-year-old man presented with a 1.3 · 0.8-cm solitary nodule on the right shoulder. The lesion was completely excised. The staging examinations did not reveal any extracutaneous involvement. One year later, there was no evidence of cutaneous and extracutaneous disease. Blood examinations revealed a mild lymphocytosis but no atypical lymphocytes. All findings were normal at the last follow-up 26 months after diagnosis.
Histopathologic, Immunophenotypic, and Molecular Findings
Common to all cases was a dense nodular to diffuse dermal infiltrate composed mainly of small-and mediumsized lymphocytes, which were separated from the overlying epidermis by a variably thick Grenz zone (Figs. 1C, 3A, 3B). The epidermis was either normal or focally atrophic with a loss of the undulated pattern. Specifically, no epidermotropism was observed in any of the biopsies of all 3 patients ( Fig. 3B ). In all biopsies, the small-to medium-sized lymphocytes showed chromatin-dense nuclei with mild to moderate nuclear pleomorphism with cleaved nuclei (Figs. 1D, 3C). A few eosinophilic granulocytes were admixed. In patient 1, several biopsies showed a granulomatous component with numerous histiocytes occasionally forming small epithelioid granulomas in addition to the lymphocytic infiltrate ( Fig. 1E ). In addition, the lymphocytic infiltrates were centered on a slightly hyperplastic hair follicle, but there was no folliculotropism in one of the biopsies of the acral lesions in patient 1 (Fig. 1C) .
Immunohistochemically, the small-to medium-sized lymphocytes were strongly positive for CD8, with about 80%-90% of the lymphocytes staining for this marker in each specimen (Figs. 1F, 3D, 3E) ( Table) . A minority of the small lymphocytes (10%-30% of the cells) expressed CD4 (Figs. 1G, 3F). The cells expressed other T-cell markers [CD2, CD3 (except for patient 3), CD5, and CD7] and were positive for beta F1 (Fig. 3G ). The CD8+ lymphocytes were negative for TIA-1, but granzyme B was expressed by 60%-70% of the small-to medium-sized lymphocytes in the biopsies of patients 1 and 2. In the biopsies of all patients, the lymphocytes were consistently negative for CD30 and CD56. There was an admixture of scattered medium-sized B cells in the biopsy of patient 3. Less than 10 percent of the small-to medium-sized CD8+ lymphocytes displayed proliferative activity in the Ki67/MIB-1 staining (Fig. 1H ). In the 2 patients (patients 1 and 3), from whom multiple biopsies were studied, the immunoprofile of the lymphoid cells was identical in each specimen. In situ hybridization for EBV RNA performed in biopsies of all patients was negative.
Molecular biologic T-cell clonality analyses revealed a clonal T-cell population in the biopsy of patients 2 and 3, whereas the infiltrates in patient 1 were polyclonal (Table) .
DISCUSSION
The common clinicopathologic features to all our cases are papulonodular or plaque-like lesions without preceding patches and histologically nodular proliferations of small-to medium-sized CD8+ lymphocytes lacking ·20) . B, The lymphocytic infiltrates were separated from the overlying epidermis by an infiltrate-free Grenz zone (H&E, original magnification ·200). C, The infiltrates consisted of small-to mediumsized pleomorphic lymphocytes (H&E, original magnification ·400). D, CD8 (red) is expressed by nearly all lymphocytes (immunohistochemistry, original magnification ·100). E, CD8 (red) is expressed by more than 80% of the small-to medium-sized pleomorphic lymphocytes (immunohistochemistry, original magnification ·200). F, Expression of CD4 (red) is found by less than 10% of the small-to medium-sized pleomorphic lymphocytes (immunohistochemistry, original magnification ·200). G, Less than 25% of the small-to medium-sized pleomorphic lymphocytes express CD3 (red) (immunohistochemistry, original magnification ·200).
epidermotropism. In the context of cutaneous lymphoid infiltrates, cases showing a cytotoxic phenotype should always alert the pathologist to a possibility of an aggressive cutaneous lymphoma, but the lesions in our 3 patients are clearly different, both clinically and histopathologically, from aggressive cytotoxic lymphomas such as primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma and other aggressive lymphoma type in which CD8 expression is commonly or occasionally observed such as subcutaneous panniculitis-like T-cell lymphoma, cutaneous gamma/delta T-cell lymphoma, and extranodal NK/T-cell lymphoma, nasal type. [13] [14] [15] CD8 phenotype has rarely been observed in less aggressive or rather indolent CTCL including MF, pagetoid reticulosis, and CD30+ anaplastic large cell lymphoma. [16] [17] [18] [19] A cytotoxic infiltrate has recently been found in peculiar form of lupus erythematosus, which showed overlapping clinicopathologic features of subcutaneous panniculitis-like T-cell lymphoma and lupus erythematosus. 20 All the above diagnoses were clearly excluded in our patients. In particular, the lack of epidermotropism in all biopsies and the absence of preceding patches argue against CD8+ variant of MF and primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. Cutaneous gamma/delta lymphoma is excluded by the presence of beta F1 expression. The indolent clinical course and the lack of association with EBV exclude extranodal NK/T-cell lymphoma.
Histopathologically, our cases are very similar to those reported as indolent CD8+ lymphoid proliferation of the ear (or face), but in all our patients, the lesions were located in extrafacial sites. So far, 5 patients (including our 3 patients) with CD8+ small-sized/medium-sized lymphoid infiltrates at extrafacial sites have been reported. 9,10 Their clinicopathologic features are summarized in the Table. Clinically and histologically, our cases are very similar or even identical to the patient reported by Khamaysi et al, 10 which was interpreted by the authors as CD8+ small-to medium-sized pleomorphic CTCL. Classification of the CD8+ lymphoid infiltrates in our cases is challenging. Although the term cutaneous peripheral T-cell lymphoma, NOS (PTL, NOS), can be applied to cases that do not fit into any of the welldefined forms of CTCL and CD8 phenotype has indeed been observed in PTL, NOS, including cases with small-to medium-sized cytomorphology, such tumors usually run an aggressive clinical course. In a large study, cytotoxic phenotype was found in about 15% of PTL, NOS and a median survival of the affected patients was 28 months. 11 Clinically, our cases show a similar biologic behavior as seen in CD4+ SMPTL, which manifests in the majority of the patients with solitary or grouped plaques or nodules and runs an indolent course with an excellent prognosis. 11, 21 Therefore, our cases could be regarded as a phenotypic CD8+ analogue to the CD4+ SMPTL (Fig. 4) . The presence of small-and medium-sized lymphocytes with nuclear atypia, the detection of clonal T cells in 2 of 3 cases, and the relapses in one of the patients are in favor of a lymphoma. In regard to the indolent course and the overlapping histologic features, some authors have indicated that CD4+ SMPTL cannot be distinguished with certainty form nodular pseudo-T-cell lymphoma and therefore proposed the term "cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance." 21, 22 In fact, some cases of pseudolymphoma composed of small-and occasional medium-sized cells may be overdiagnosed at present as small-to medium-sized pleomorphic T-cell lymphoma. 21, 23 Moreover, a CD8 phenotype has been reported in rare cutaneous FIGURE 4 . Primary cutaneous CD8+ small-sized/medium-sized T-cell lymphoproliferative disorder shows overlapping features with primary cutaneous CD4+ small-sized/medium-sized T-cell lymphoma (with the exception of the CD8+ phenotype), nodular T-cell pseudolymphoma, and CD8+ indolent lymphoid proliferation of the ear and face, respectively. Primary cutaneous CD4+ small-to medium-sized T-cell lymphoma and cutaneous CD8+ small-to medium-sized T-cell lymphoproliferative disorder display an excellent prognosis when presenting with a solitary lesion but may carry the risk for a more aggressive course in patients with multifocal lesions. pseudolymphomas in human immunodeficiency virus-positive patients and other conditions characterized by lymphoid infiltrates, including lymphoid infiltration of Jessner-Kanof and palpable arciform migratory erythema. [24] [25] [26] These lesions feature a less prominent infiltrate composed almost exclusively of small cells. The possibility that the infiltrate in our patient 3 represents a form of pseudolymphoma (reactive lymphoid hyperplasia) cannot be totally refuted. The history did not indicate a drug-related form of pseudolymphoma as no association with drug intake had been reported by the patient. In addition, the lack of CD3 expression by the smallto medium-sized tumor cells in case 3 argues against pseudolymphoma.
Patients with SMPTL seem to have a favorable prognosis independent of their CD4 or CD8-positive phenotype, especially those with a solitary lesion. 9, 10, 23, 27 Nevertheless, the relapsing course and the multifocal occurrence of tumors in patient 1 may indicate that the extrafacial CD8+ lymphoid proliferations are a prognostically heterogenous group, as the same course has also been reported in CD4+ SMPTL. In the latter entity, cases with multiple rapidly growing tumors and a high proliferation rate may run a more aggressive course. 28 Thus, a patient with multiple lesions should be followed more intensively and may require more intense treatment.
A surprising feature observed in one case (case 1) was the conspicuous granulomatous component of the infiltrate. In the context of cutaneous lymphomas, granulomatous features are typically present in granulomatous slack skin and granulomatous MF and are rare in other lymphoma types. [29] [30] [31] [32] They have also been described in pseudolymphomatous folliculitis, a term used to describe a distinctive pattern seen in both lymphomas and pseudolymphomas. 33, 34 Along this line, some cases of "pseudolymphomatous folliculitis" and small-to medium-sized pleomorphic CTCL show a great clinicopathologic overlap. [34] [35] [36] In our patient with Bruton X-linked agammaglobulinemia, the granulomatous (and lymphomatous) infiltrate may be related to immunodeficiency or immunoglobulin substitution. Similar histopathologic findings have recently been reported in a Japanese patient with X-linked agammaglobulinemia, including a heavy small-to medium-sized nonepidermotropic lymphoid infiltrate with cytotoxic CD8+ phenotype and a great admixture of histiocytes. 37 The tumor was classified as peripheral CTCL, NOS, and the patient clinically presented with multiple papules, macules, and patches on the face and trunk. 37 In conclusion, we report a series of CD8+ small-to medium-sized cell lymphoid proliferations of the skin with an indolent behavior similar to those reported for CD8+ lymphoid proliferation on the ear and face, but all occurring in extrafacial sites. Further observations are needed to collect a larger number of such cases to get insight into the biologic nature of the lesion-lymphoma or reactive process-and to find out whether they represent a prognostically heterogeneous group of lesions. If such lymphoid proliferations should be classified as lymphoma, then according to the currently used scheme (World Health Organization classification, 2008, 4th edition), they would conform to the concept of cutaneous PTL, NOS, and could perhaps be regarded as the CD8+ analogue of CD4+ SMPTL within a larger spectrum of nodular infiltrates of small-to medium-sized pleomorphic lymphocytes (Fig. 4) . We propose the term primary cutaneous CD8+ small-to medium-sized lymphoproliferative disorder. A growing body of evidence suggests that what is now called small-to medium-sized pleomorphic CTCL may in fact represent a phenotypically and prognostically heterogeneous group of lymphoid proliferations. 28 
